WELL Health Technologies Corp.
WELL.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 16.90% | 35.32% | 40.10% | 34.43% | 31.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.90% | 35.32% | 40.10% | 34.43% | 31.60% |
| Cost of Revenue | 35.78% | 51.46% | 62.77% | 51.32% | 46.66% |
| Gross Profit | -3.57% | 19.25% | 19.36% | 19.05% | 18.41% |
| SG&A Expenses | 35.25% | 48.43% | 54.51% | 55.59% | 24.25% |
| Depreciation & Amortization | 17.09% | 16.16% | 15.44% | 9.29% | 6.10% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 53.75% | 69.20% | 79.08% | 73.71% | 33.48% |
| Operating Income | -102.87% | 53.27% | 27.30% | 35.75% | 0.99% |
| Income Before Tax | -47.74% | 2,797.07% | 1,318.11% | 533.51% | 11.19% |
| Income Tax Expenses | -778.03% | 85.18% | -188.71% | 185.19% | 376.34% |
| Earnings from Continuing Operations | 80.07% | 1,840.79% | 1,546.21% | 336.48% | -10.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 117.93% | -73.72% | -32.58% | -9.85% | 8.83% |
| Net Income | 17,823.76% | 1,098.72% | 3,573.40% | 672.74% | -202.57% |
| EBIT | -102.87% | 53.27% | 27.30% | 35.75% | 0.99% |
| EBITDA | -16.34% | 49.68% | 38.10% | 37.87% | 1.66% |
| EPS Basic | 3,692.59% | 1,139.53% | 3,584.13% | 611.49% | 25.00% |
| Normalized Basic EPS | -181.31% | -109.30% | -109.28% | -88.25% | -16.53% |
| EPS Diluted | 1,777.94% | 1,067.97% | 2,889.82% | 843.68% | -88.89% |
| Normalized Diluted EPS | -180.28% | -107.61% | -107.73% | -88.25% | -16.53% |
| Average Basic Shares Outstanding | 1.66% | 4.61% | 4.73% | 5.78% | 7.20% |
| Average Diluted Shares Outstanding | 3.41% | 6.38% | 6.52% | 5.78% | 7.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |